2015-2027 Global Next Generation Cancer Diagnostics Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for Next Generation Cancer Diagnostics is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Myriad Genetics
F. Hoffmann-La Roche Ltd
Sysmex Corporation
Agilent Technologies
PerkinElmer
Opko Health
Janssen Global Services
Almac Group
GE Healthcare
Qiagen
Cepheid
Koninklijke Philips N.V
Abbott
Illumina
Hologic
Genomic Health
Novartis AG
Thermo Fisher Scientific
Major Types Covered
Next Generation Sequencing
QPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
Major Applications Covered
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Myriad Genetics
F. Hoffmann-La Roche Ltd
Sysmex Corporation
Agilent Technologies
PerkinElmer
Opko Health
Janssen Global Services
Almac Group
GE Healthcare
Qiagen
Cepheid
Koninklijke Philips N.V
Abbott
Illumina
Hologic
Genomic Health
Novartis AG
Thermo Fisher Scientific
Major Types Covered
Next Generation Sequencing
QPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
Major Applications Covered
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Next Generation Cancer Diagnostics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Next Generation Cancer Diagnostics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE NEXT GENERATION CANCER DIAGNOSTICS MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY TYPE
5.1 Next Generation Sequencing
5.2 QPCR & Multiplexing
5.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
5.4 Protein Microarrays
5.5 DNA Microarrays
6 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY APPLICATION
6.1 Lung Cancer
6.2 Breast Cancer
6.3 Colorectal Cancer
6.4 Cervical Cancer
6.5 Others
7 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Myriad Genetics
8.1.1 Myriad Genetics Profile
8.1.2 Myriad Genetics Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Myriad Genetics Product/Solution Launches and Enhancements Analysis
8.1.4 Myriad Genetics Business Overview/Recent Development/Acquisitions
8.2 F. Hoffmann-La Roche Ltd
8.2.1 F. Hoffmann-La Roche Ltd Profile
8.2.2 F. Hoffmann-La Roche Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 F. Hoffmann-La Roche Ltd Product/Solution Launches and Enhancements Analysis
8.2.4 F. Hoffmann-La Roche Ltd Business Overview/Recent Development/Acquisitions
8.3 Sysmex Corporation
8.3.1 Sysmex Corporation Profile
8.3.2 Sysmex Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Sysmex Corporation Product/Solution Launches and Enhancements Analysis
8.3.4 Sysmex Corporation Business Overview/Recent Development/Acquisitions
8.4 Agilent Technologies
8.4.1 Agilent Technologies Profile
8.4.2 Agilent Technologies Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Agilent Technologies Product/Solution Launches and Enhancements Analysis
8.4.4 Agilent Technologies Business Overview/Recent Development/Acquisitions
8.5 PerkinElmer
8.5.1 PerkinElmer Profile
8.5.2 PerkinElmer Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 PerkinElmer Product/Solution Launches and Enhancements Analysis
8.5.4 PerkinElmer Business Overview/Recent Development/Acquisitions
8.6 Opko Health
8.6.1 Opko Health Profile
8.6.2 Opko Health Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Opko Health Product/Solution Launches and Enhancements Analysis
8.6.4 Opko Health Business Overview/Recent Development/Acquisitions
8.7 Janssen Global Services
8.7.1 Janssen Global Services Profile
8.7.2 Janssen Global Services Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Janssen Global Services Product/Solution Launches and Enhancements Analysis
8.7.4 Janssen Global Services Business Overview/Recent Development/Acquisitions
8.8 Almac Group
8.8.1 Almac Group Profile
8.8.2 Almac Group Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Almac Group Product/Solution Launches and Enhancements Analysis
8.8.4 Almac Group Business Overview/Recent Development/Acquisitions
8.9 GE Healthcare
8.9.1 GE Healthcare Profile
8.9.2 GE Healthcare Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 GE Healthcare Product/Solution Launches and Enhancements Analysis
8.9.4 GE Healthcare Business Overview/Recent Development/Acquisitions
8.10 Qiagen
8.10.1 Qiagen Profile
8.10.2 Qiagen Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Qiagen Product/Solution Launches and Enhancements Analysis
8.10.4 Qiagen Business Overview/Recent Development/Acquisitions
8.11 Cepheid
8.11.1 Cepheid Profile
8.11.2 Cepheid Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Cepheid Product/Solution Launches and Enhancements Analysis
8.11.4 Cepheid Business Overview/Recent Development/Acquisitions
8.12 Koninklijke Philips N.V
8.12.1 Koninklijke Philips N.V Profile
8.12.2 Koninklijke Philips N.V Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Koninklijke Philips N.V Product/Solution Launches and Enhancements Analysis
8.12.4 Koninklijke Philips N.V Business Overview/Recent Development/Acquisitions
8.13 Abbott
8.13.1 Abbott Profile
8.13.2 Abbott Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Abbott Product/Solution Launches and Enhancements Analysis
8.13.4 Abbott Business Overview/Recent Development/Acquisitions
8.14 Illumina
8.14.1 Illumina Profile
8.14.2 Illumina Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Illumina Product/Solution Launches and Enhancements Analysis
8.14.4 Illumina Business Overview/Recent Development/Acquisitions
8.15 Hologic
8.15.1 Hologic Profile
8.15.2 Hologic Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Hologic Product/Solution Launches and Enhancements Analysis
8.15.4 Hologic Business Overview/Recent Development/Acquisitions
8.16 Genomic Health
8.16.1 Genomic Health Profile
8.16.2 Genomic Health Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Genomic Health Product/Solution Launches and Enhancements Analysis
8.16.4 Genomic Health Business Overview/Recent Development/Acquisitions
8.17 Novartis AG
8.17.1 Novartis AG Profile
8.17.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 Novartis AG Product/Solution Launches and Enhancements Analysis
8.17.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.18 Thermo Fisher Scientific
8.18.1 Thermo Fisher Scientific Profile
8.18.2 Thermo Fisher Scientific Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Thermo Fisher Scientific Product/Solution Launches and Enhancements Analysis
8.18.4 Thermo Fisher Scientific Business Overview/Recent Development/Acquisitions
9 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Next Generation Cancer Diagnostics Production Analysis from 2015-2020
10.4 North America Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
10.5 North America Next Generation Cancer Diagnostics Import and Export from 2015-2020
10.6 North America Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
10.7 North America Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Next Generation Cancer Diagnostics by Country (United States, Canada)
10.8.1 North America Next Generation Cancer Diagnostics Sales by Country (2015-2020)
10.8.2 North America Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
10.9 North America Next Generation Cancer Diagnostics Market PEST Analysis
11 EUROPE
11.1 Europe Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Next Generation Cancer Diagnostics Production Analysis from 2015-2020
11.4 Europe Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
11.5 Europe Next Generation Cancer Diagnostics Import and Export from 2015-2020
11.6 Europe Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Next Generation Cancer Diagnostics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Next Generation Cancer Diagnostics Sales by Country (2015-2020)
11.8.2 Europe Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
11.9 Europe Next Generation Cancer Diagnostics Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Next Generation Cancer Diagnostics Production Analysis from 2015-2020
12.4 Asia-Pacific Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Next Generation Cancer Diagnostics Import and Export from 2015-2020
12.6 Asia-Pacific Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Next Generation Cancer Diagnostics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Next Generation Cancer Diagnostics Sales by Country (2015-2020)
12.8.2 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Next Generation Cancer Diagnostics Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Next Generation Cancer Diagnostics Production Analysis from 2015-2020
13.4 Latin America Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
13.5 Latin America Next Generation Cancer Diagnostics Import and Export from 2015-2020
13.6 Latin America Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Next Generation Cancer Diagnostics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Next Generation Cancer Diagnostics Sales by Country (2015-2020)
13.8.2 Latin America Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
13.9 Latin America Next Generation Cancer Diagnostics Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Next Generation Cancer Diagnostics Production Analysis from 2015-2020
14.4 Middle East & Africa Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Next Generation Cancer Diagnostics Import and Export from 2015-2020
14.6 Middle East & Africa Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Next Generation Cancer Diagnostics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Next Generation Cancer Diagnostics Sales by Country (2015-2020)
14.8.2 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Next Generation Cancer Diagnostics Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET FROM 2020-2027
15.1 Future Forecast of the Global Next Generation Cancer Diagnostics Market from 2020-2027 Segment by Region
15.2 Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Next Generation Cancer Diagnostics Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Next Generation Cancer Diagnostics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Next Generation Cancer Diagnostics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE NEXT GENERATION CANCER DIAGNOSTICS MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY TYPE
5.1 Next Generation Sequencing
5.2 QPCR & Multiplexing
5.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
5.4 Protein Microarrays
5.5 DNA Microarrays
6 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY APPLICATION
6.1 Lung Cancer
6.2 Breast Cancer
6.3 Colorectal Cancer
6.4 Cervical Cancer
6.5 Others
7 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Myriad Genetics
8.1.1 Myriad Genetics Profile
8.1.2 Myriad Genetics Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Myriad Genetics Product/Solution Launches and Enhancements Analysis
8.1.4 Myriad Genetics Business Overview/Recent Development/Acquisitions
8.2 F. Hoffmann-La Roche Ltd
8.2.1 F. Hoffmann-La Roche Ltd Profile
8.2.2 F. Hoffmann-La Roche Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 F. Hoffmann-La Roche Ltd Product/Solution Launches and Enhancements Analysis
8.2.4 F. Hoffmann-La Roche Ltd Business Overview/Recent Development/Acquisitions
8.3 Sysmex Corporation
8.3.1 Sysmex Corporation Profile
8.3.2 Sysmex Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Sysmex Corporation Product/Solution Launches and Enhancements Analysis
8.3.4 Sysmex Corporation Business Overview/Recent Development/Acquisitions
8.4 Agilent Technologies
8.4.1 Agilent Technologies Profile
8.4.2 Agilent Technologies Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Agilent Technologies Product/Solution Launches and Enhancements Analysis
8.4.4 Agilent Technologies Business Overview/Recent Development/Acquisitions
8.5 PerkinElmer
8.5.1 PerkinElmer Profile
8.5.2 PerkinElmer Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 PerkinElmer Product/Solution Launches and Enhancements Analysis
8.5.4 PerkinElmer Business Overview/Recent Development/Acquisitions
8.6 Opko Health
8.6.1 Opko Health Profile
8.6.2 Opko Health Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Opko Health Product/Solution Launches and Enhancements Analysis
8.6.4 Opko Health Business Overview/Recent Development/Acquisitions
8.7 Janssen Global Services
8.7.1 Janssen Global Services Profile
8.7.2 Janssen Global Services Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Janssen Global Services Product/Solution Launches and Enhancements Analysis
8.7.4 Janssen Global Services Business Overview/Recent Development/Acquisitions
8.8 Almac Group
8.8.1 Almac Group Profile
8.8.2 Almac Group Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Almac Group Product/Solution Launches and Enhancements Analysis
8.8.4 Almac Group Business Overview/Recent Development/Acquisitions
8.9 GE Healthcare
8.9.1 GE Healthcare Profile
8.9.2 GE Healthcare Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 GE Healthcare Product/Solution Launches and Enhancements Analysis
8.9.4 GE Healthcare Business Overview/Recent Development/Acquisitions
8.10 Qiagen
8.10.1 Qiagen Profile
8.10.2 Qiagen Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Qiagen Product/Solution Launches and Enhancements Analysis
8.10.4 Qiagen Business Overview/Recent Development/Acquisitions
8.11 Cepheid
8.11.1 Cepheid Profile
8.11.2 Cepheid Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Cepheid Product/Solution Launches and Enhancements Analysis
8.11.4 Cepheid Business Overview/Recent Development/Acquisitions
8.12 Koninklijke Philips N.V
8.12.1 Koninklijke Philips N.V Profile
8.12.2 Koninklijke Philips N.V Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Koninklijke Philips N.V Product/Solution Launches and Enhancements Analysis
8.12.4 Koninklijke Philips N.V Business Overview/Recent Development/Acquisitions
8.13 Abbott
8.13.1 Abbott Profile
8.13.2 Abbott Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Abbott Product/Solution Launches and Enhancements Analysis
8.13.4 Abbott Business Overview/Recent Development/Acquisitions
8.14 Illumina
8.14.1 Illumina Profile
8.14.2 Illumina Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Illumina Product/Solution Launches and Enhancements Analysis
8.14.4 Illumina Business Overview/Recent Development/Acquisitions
8.15 Hologic
8.15.1 Hologic Profile
8.15.2 Hologic Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Hologic Product/Solution Launches and Enhancements Analysis
8.15.4 Hologic Business Overview/Recent Development/Acquisitions
8.16 Genomic Health
8.16.1 Genomic Health Profile
8.16.2 Genomic Health Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Genomic Health Product/Solution Launches and Enhancements Analysis
8.16.4 Genomic Health Business Overview/Recent Development/Acquisitions
8.17 Novartis AG
8.17.1 Novartis AG Profile
8.17.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 Novartis AG Product/Solution Launches and Enhancements Analysis
8.17.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.18 Thermo Fisher Scientific
8.18.1 Thermo Fisher Scientific Profile
8.18.2 Thermo Fisher Scientific Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Thermo Fisher Scientific Product/Solution Launches and Enhancements Analysis
8.18.4 Thermo Fisher Scientific Business Overview/Recent Development/Acquisitions
9 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Next Generation Cancer Diagnostics Production Analysis from 2015-2020
10.4 North America Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
10.5 North America Next Generation Cancer Diagnostics Import and Export from 2015-2020
10.6 North America Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
10.7 North America Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Next Generation Cancer Diagnostics by Country (United States, Canada)
10.8.1 North America Next Generation Cancer Diagnostics Sales by Country (2015-2020)
10.8.2 North America Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
10.9 North America Next Generation Cancer Diagnostics Market PEST Analysis
11 EUROPE
11.1 Europe Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Next Generation Cancer Diagnostics Production Analysis from 2015-2020
11.4 Europe Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
11.5 Europe Next Generation Cancer Diagnostics Import and Export from 2015-2020
11.6 Europe Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Next Generation Cancer Diagnostics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Next Generation Cancer Diagnostics Sales by Country (2015-2020)
11.8.2 Europe Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
11.9 Europe Next Generation Cancer Diagnostics Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Next Generation Cancer Diagnostics Production Analysis from 2015-2020
12.4 Asia-Pacific Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Next Generation Cancer Diagnostics Import and Export from 2015-2020
12.6 Asia-Pacific Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Next Generation Cancer Diagnostics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Next Generation Cancer Diagnostics Sales by Country (2015-2020)
12.8.2 Asia-Pacific Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Next Generation Cancer Diagnostics Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Next Generation Cancer Diagnostics Production Analysis from 2015-2020
13.4 Latin America Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
13.5 Latin America Next Generation Cancer Diagnostics Import and Export from 2015-2020
13.6 Latin America Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Next Generation Cancer Diagnostics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Next Generation Cancer Diagnostics Sales by Country (2015-2020)
13.8.2 Latin America Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
13.9 Latin America Next Generation Cancer Diagnostics Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Next Generation Cancer Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Next Generation Cancer Diagnostics Production Analysis from 2015-2020
14.4 Middle East & Africa Next Generation Cancer Diagnostics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Next Generation Cancer Diagnostics Import and Export from 2015-2020
14.6 Middle East & Africa Next Generation Cancer Diagnostics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Next Generation Cancer Diagnostics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Next Generation Cancer Diagnostics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Next Generation Cancer Diagnostics Sales by Country (2015-2020)
14.8.2 Middle East & Africa Next Generation Cancer Diagnostics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Next Generation Cancer Diagnostics Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET FROM 2020-2027
15.1 Future Forecast of the Global Next Generation Cancer Diagnostics Market from 2020-2027 Segment by Region
15.2 Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Next Generation Cancer Diagnostics Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES
Global Next Generation Cancer Diagnostics Market Value ($) and Growth Rate of Next Generation Cancer Diagnostics from 2015-2027
Global Next Generation Cancer Diagnostics Production and Growth Rate Segment by Product Type from 2015-2027
Global Next Generation Cancer Diagnostics Consumption and Growth Rate Segment by Application from 2015-2027
Figure Next Generation Cancer Diagnostics Picture
Table Product Specifications of Next Generation Cancer Diagnostics
Table Driving Factors for this Market
Table Industry News of Next Generation Cancer Diagnostics Market
Figure Value Chain Status of Next Generation Cancer Diagnostics
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Next Generation Cancer Diagnostics Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Next Generation Sequencing of Next Generation Cancer Diagnostics
Figure QPCR & Multiplexing of Next Generation Cancer Diagnostics
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) of Next Generation Cancer Diagnostics
Figure Protein Microarrays of Next Generation Cancer Diagnostics
Figure DNA Microarrays of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Lung Cancer of Next Generation Cancer Diagnostics
Figure Breast Cancer of Next Generation Cancer Diagnostics
Figure Colorectal Cancer of Next Generation Cancer Diagnostics
Figure Cervical Cancer of Next Generation Cancer Diagnostics
Figure Others of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Next Generation Cancer Diagnostics
Figure Online Channel of Next Generation Cancer Diagnostics
Table Myriad Genetics Profile (Company Name, Plants Distribution, Sales Region)
Figure Myriad Genetics Sales and Growth Rate from 2015-2020
Figure Myriad Genetics Revenue ($) and Global Market Share from 2015-2020
Table Myriad Genetics Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table F. Hoffmann-La Roche Ltd Profile (Company Name, Plants Distribution, Sales Region)
Figure F. Hoffmann-La Roche Ltd Sales and Growth Rate from 2015-2020
Figure F. Hoffmann-La Roche Ltd Revenue ($) and Global Market Share from 2015-2020
Table F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sysmex Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Sysmex Corporation Sales and Growth Rate from 2015-2020
Figure Sysmex Corporation Revenue ($) and Global Market Share from 2015-2020
Table Sysmex Corporation Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Agilent Technologies Profile (Company Name, Plants Distribution, Sales Region)
Figure Agilent Technologies Sales and Growth Rate from 2015-2020
Figure Agilent Technologies Revenue ($) and Global Market Share from 2015-2020
Table Agilent Technologies Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table PerkinElmer Profile (Company Name, Plants Distribution, Sales Region)
Figure PerkinElmer Sales and Growth Rate from 2015-2020
Figure PerkinElmer Revenue ($) and Global Market Share from 2015-2020
Table PerkinElmer Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Opko Health Profile (Company Name, Plants Distribution, Sales Region)
Figure Opko Health Sales and Growth Rate from 2015-2020
Figure Opko Health Revenue ($) and Global Market Share from 2015-2020
Table Opko Health Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Janssen Global Services Profile (Company Name, Plants Distribution, Sales Region)
Figure Janssen Global Services Sales and Growth Rate from 2015-2020
Figure Janssen Global Services Revenue ($) and Global Market Share from 2015-2020
Table Janssen Global Services Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Almac Group Profile (Company Name, Plants Distribution, Sales Region)
Figure Almac Group Sales and Growth Rate from 2015-2020
Figure Almac Group Revenue ($) and Global Market Share from 2015-2020
Table Almac Group Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table GE Healthcare Profile (Company Name, Plants Distribution, Sales Region)
Figure GE Healthcare Sales and Growth Rate from 2015-2020
Figure GE Healthcare Revenue ($) and Global Market Share from 2015-2020
Table GE Healthcare Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Qiagen Profile (Company Name, Plants Distribution, Sales Region)
Figure Qiagen Sales and Growth Rate from 2015-2020
Figure Qiagen Revenue ($) and Global Market Share from 2015-2020
Table Qiagen Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cepheid Profile (Company Name, Plants Distribution, Sales Region)
Figure Cepheid Sales and Growth Rate from 2015-2020
Figure Cepheid Revenue ($) and Global Market Share from 2015-2020
Table Cepheid Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Koninklijke Philips N.V Profile (Company Name, Plants Distribution, Sales Region)
Figure Koninklijke Philips N.V Sales and Growth Rate from 2015-2020
Figure Koninklijke Philips N.V Revenue ($) and Global Market Share from 2015-2020
Table Koninklijke Philips N.V Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Sales and Growth Rate from 2015-2020
Figure Abbott Revenue ($) and Global Market Share from 2015-2020
Table Abbott Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Illumina Profile (Company Name, Plants Distribution, Sales Region)
Figure Illumina Sales and Growth Rate from 2015-2020
Figure Illumina Revenue ($) and Global Market Share from 2015-2020
Table Illumina Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Hologic Profile (Company Name, Plants Distribution, Sales Region)
Figure Hologic Sales and Growth Rate from 2015-2020
Figure Hologic Revenue ($) and Global Market Share from 2015-2020
Table Hologic Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genomic Health Profile (Company Name, Plants Distribution, Sales Region)
Figure Genomic Health Sales and Growth Rate from 2015-2020
Figure Genomic Health Revenue ($) and Global Market Share from 2015-2020
Table Genomic Health Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Thermo Fisher Scientific Profile (Company Name, Plants Distribution, Sales Region)
Figure Thermo Fisher Scientific Sales and Growth Rate from 2015-2020
Figure Thermo Fisher Scientific Revenue ($) and Global Market Share from 2015-2020
Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Next Generation Cancer Diagnostics Production Value ($) by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Production Value Share by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Production by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Consumption Value ($) by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Consumption by Region from 2015-2020
Table North America Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table North America Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table North America Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table North America Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table North America Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table North America Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure North America Next Generation Cancer Diagnostics Market PEST Analysis
Table Europe Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Europe Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Europe Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Europe Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Europe Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Europe Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Europe Next Generation Cancer Diagnostics Market PEST Analysis
Table Asia-Pacific Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Asia-Pacific Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Next Generation Cancer Diagnostics Market PEST Analysis
Table Latin America Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Latin America Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Latin America Next Generation Cancer Diagnostics Market PEST Analysis
Table Middle East & Africa Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Middle East & Africa Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Next Generation Cancer Diagnostics Market PEST Analysis
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast by Region (2020-2027)
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast by Type (2020-2027)
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Forecast by Application (2020-2027)
Global Next Generation Cancer Diagnostics Market Value ($) and Growth Rate of Next Generation Cancer Diagnostics from 2015-2027
Global Next Generation Cancer Diagnostics Production and Growth Rate Segment by Product Type from 2015-2027
Global Next Generation Cancer Diagnostics Consumption and Growth Rate Segment by Application from 2015-2027
Figure Next Generation Cancer Diagnostics Picture
Table Product Specifications of Next Generation Cancer Diagnostics
Table Driving Factors for this Market
Table Industry News of Next Generation Cancer Diagnostics Market
Figure Value Chain Status of Next Generation Cancer Diagnostics
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Next Generation Cancer Diagnostics Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Next Generation Sequencing of Next Generation Cancer Diagnostics
Figure QPCR & Multiplexing of Next Generation Cancer Diagnostics
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) of Next Generation Cancer Diagnostics
Figure Protein Microarrays of Next Generation Cancer Diagnostics
Figure DNA Microarrays of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Lung Cancer of Next Generation Cancer Diagnostics
Figure Breast Cancer of Next Generation Cancer Diagnostics
Figure Colorectal Cancer of Next Generation Cancer Diagnostics
Figure Cervical Cancer of Next Generation Cancer Diagnostics
Figure Others of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Next Generation Cancer Diagnostics
Figure Online Channel of Next Generation Cancer Diagnostics
Table Myriad Genetics Profile (Company Name, Plants Distribution, Sales Region)
Figure Myriad Genetics Sales and Growth Rate from 2015-2020
Figure Myriad Genetics Revenue ($) and Global Market Share from 2015-2020
Table Myriad Genetics Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table F. Hoffmann-La Roche Ltd Profile (Company Name, Plants Distribution, Sales Region)
Figure F. Hoffmann-La Roche Ltd Sales and Growth Rate from 2015-2020
Figure F. Hoffmann-La Roche Ltd Revenue ($) and Global Market Share from 2015-2020
Table F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sysmex Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Sysmex Corporation Sales and Growth Rate from 2015-2020
Figure Sysmex Corporation Revenue ($) and Global Market Share from 2015-2020
Table Sysmex Corporation Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Agilent Technologies Profile (Company Name, Plants Distribution, Sales Region)
Figure Agilent Technologies Sales and Growth Rate from 2015-2020
Figure Agilent Technologies Revenue ($) and Global Market Share from 2015-2020
Table Agilent Technologies Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table PerkinElmer Profile (Company Name, Plants Distribution, Sales Region)
Figure PerkinElmer Sales and Growth Rate from 2015-2020
Figure PerkinElmer Revenue ($) and Global Market Share from 2015-2020
Table PerkinElmer Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Opko Health Profile (Company Name, Plants Distribution, Sales Region)
Figure Opko Health Sales and Growth Rate from 2015-2020
Figure Opko Health Revenue ($) and Global Market Share from 2015-2020
Table Opko Health Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Janssen Global Services Profile (Company Name, Plants Distribution, Sales Region)
Figure Janssen Global Services Sales and Growth Rate from 2015-2020
Figure Janssen Global Services Revenue ($) and Global Market Share from 2015-2020
Table Janssen Global Services Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Almac Group Profile (Company Name, Plants Distribution, Sales Region)
Figure Almac Group Sales and Growth Rate from 2015-2020
Figure Almac Group Revenue ($) and Global Market Share from 2015-2020
Table Almac Group Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table GE Healthcare Profile (Company Name, Plants Distribution, Sales Region)
Figure GE Healthcare Sales and Growth Rate from 2015-2020
Figure GE Healthcare Revenue ($) and Global Market Share from 2015-2020
Table GE Healthcare Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Qiagen Profile (Company Name, Plants Distribution, Sales Region)
Figure Qiagen Sales and Growth Rate from 2015-2020
Figure Qiagen Revenue ($) and Global Market Share from 2015-2020
Table Qiagen Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cepheid Profile (Company Name, Plants Distribution, Sales Region)
Figure Cepheid Sales and Growth Rate from 2015-2020
Figure Cepheid Revenue ($) and Global Market Share from 2015-2020
Table Cepheid Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Koninklijke Philips N.V Profile (Company Name, Plants Distribution, Sales Region)
Figure Koninklijke Philips N.V Sales and Growth Rate from 2015-2020
Figure Koninklijke Philips N.V Revenue ($) and Global Market Share from 2015-2020
Table Koninklijke Philips N.V Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Sales and Growth Rate from 2015-2020
Figure Abbott Revenue ($) and Global Market Share from 2015-2020
Table Abbott Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Illumina Profile (Company Name, Plants Distribution, Sales Region)
Figure Illumina Sales and Growth Rate from 2015-2020
Figure Illumina Revenue ($) and Global Market Share from 2015-2020
Table Illumina Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Hologic Profile (Company Name, Plants Distribution, Sales Region)
Figure Hologic Sales and Growth Rate from 2015-2020
Figure Hologic Revenue ($) and Global Market Share from 2015-2020
Table Hologic Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genomic Health Profile (Company Name, Plants Distribution, Sales Region)
Figure Genomic Health Sales and Growth Rate from 2015-2020
Figure Genomic Health Revenue ($) and Global Market Share from 2015-2020
Table Genomic Health Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Thermo Fisher Scientific Profile (Company Name, Plants Distribution, Sales Region)
Figure Thermo Fisher Scientific Sales and Growth Rate from 2015-2020
Figure Thermo Fisher Scientific Revenue ($) and Global Market Share from 2015-2020
Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Next Generation Cancer Diagnostics Production Value ($) by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Production Value Share by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Production by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Consumption Value ($) by Region from 2015-2020
Table Global Next Generation Cancer Diagnostics Consumption by Region from 2015-2020
Table North America Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table North America Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table North America Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table North America Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table North America Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table North America Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure North America Next Generation Cancer Diagnostics Market PEST Analysis
Table Europe Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Europe Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Europe Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Europe Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Europe Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Europe Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Europe Next Generation Cancer Diagnostics Market PEST Analysis
Table Asia-Pacific Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Asia-Pacific Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Asia-Pacific Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Next Generation Cancer Diagnostics Market PEST Analysis
Table Latin America Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Latin America Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Latin America Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Latin America Next Generation Cancer Diagnostics Market PEST Analysis
Table Middle East & Africa Next Generation Cancer Diagnostics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Next Generation Cancer Diagnostics Import and Export from 2015-2020
Table Middle East & Africa Next Generation Cancer Diagnostics Value ($) by Type (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Production by Type (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption by Application (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption by Country (2015-2020)
Table Middle East & Africa Next Generation Cancer Diagnostics Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Next Generation Cancer Diagnostics Market PEST Analysis
Table Global Next Generation Cancer Diagnostics Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast by Region (2020-2027)
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast by Type (2020-2027)
Table Global Next Generation Cancer Diagnostics Consumption and Growth Rate Forecast by Application (2020-2027)
